Liquidia, a Morrisville biopharmaceutical company founded on technology from chemist Joseph DeSimone, has raised $50 million through an initial offering of public stock. It begins trading on the Nasdaq on Thursday, July 26. DeSimone is a professor at UNC Chapel Hill and N.C. State University.
Liquidia, a Morrisville biopharmaceutical company founded on technology from chemist Joseph DeSimone, has raised $50 million through an initial offering of public stock. It begins trading on the Nasdaq on Thursday, July 26. DeSimone is a professor at UNC Chapel Hill and N.C. State University. News & Observer file photo
Liquidia, a Morrisville biopharmaceutical company founded on technology from chemist Joseph DeSimone, has raised $50 million through an initial offering of public stock. It begins trading on the Nasdaq on Thursday, July 26. DeSimone is a professor at UNC Chapel Hill and N.C. State University. News & Observer file photo

Morrisville drug maker Liquidia files for $57.5M stock offering

July 02, 2018 03:20 PM